AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
RBC Capital Raises Price Target for Addus HomeCare to $134, Analyst Maintains "Outperform" Rating
ByAinvest
Friday, Aug 22, 2025 9:20 pm ET1min read
RBC Capital has raised its price target for Addus HomeCare (ADUS) to $134, maintaining its "Outperform" rating. The stock has seen several analyst actions in recent months, with Barclays raising its target to $109 and TD Cowen increasing its target to $139. The average analyst target price is $140.82, indicating a 23.33% upside from the current price of $114.18.
RBC Capital Markets has recently updated its price target for Addus HomeCare Corporation (ADUS), raising it to $134. The investment bank maintains its "Outperform" rating for the stock, reflecting a positive outlook on the company's financial prospects. This move comes amidst a flurry of analyst actions in recent months, with Barclays and TD Cowen also adjusting their price targets for ADUS.Barclays has raised its target to $109, while TD Cowen has increased its target to $139. The average analyst target price for ADUS stands at $140.82, indicating a potential 23.33% upside from the current price of $114.18 [1].
Addus HomeCare Corporation provides a range of home care services, including personal care, hospice care, and home health services. These segments cater to various patient needs, from non-medical assistance with activities of daily living to palliative care and skilled nursing services [2].
The latest price target adjustment by RBC Capital Markets underscores the analyst community's optimism regarding ADUS's growth potential. As the demand for home care services continues to rise, driven by an aging population and increased healthcare needs, companies like Addus HomeCare are well-positioned to benefit.
Investors should closely monitor ADUS's financial performance and any updates from the company or analysts to gauge the stock's future prospects. Given the current analyst consensus and price targets, ADUS presents an intriguing opportunity for investors seeking exposure to the home care sector.
References:
[1] https://www.marketscreener.com/news/addus-homecare-insider-sold-shares-worth-2-873-851-according-to-a-recent-sec-filing-ce7c50dad88ff52c
[2] https://www.marketbeat.com/ratings/by-issuer/royal-bank-of-canada-stock-recommendations/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet